adenosine diphosphate has been researched along with fenofibrate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Drouin, P; Dumont, E; Morazain, R; Renaud, S; Sauvanet, JP | 1 |
Cirillo, R; Franzone, JS; Pernigotti, LM; Reboani, MC; Torrielli, MV | 1 |
Long, X; Lv, M; Xie, D | 1 |
3 other study(ies) available for adenosine diphosphate and fenofibrate
Article | Year |
---|---|
Influence of a hypolipemic drug (procetofene) on platelet functions and lipid composition in type II B hyperlipoproteinemia.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation; Cholesterol; Epinephrine; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Phospholipids; Platelet Aggregation; Propionates; Triglycerides | 1979 |
Effect of teomorfolin [N-(7'-theophylline acetyl)morpholine], a new drug, on dislipidaemic conditions induced in the rat.
Topics: Adenosine Diphosphate; Animals; Blood Glucose; Diet, Atherogenic; Epoprostenol; Erythrocyte Deformability; Fatty Acids, Nonesterified; Fenofibrate; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Male; Morpholines; Platelet Aggregation; Rats; Rats, Inbred Strains; Theophylline | 1988 |
The effect of fenofibrate, a peroxisome proliferator-activated receptor α agonist, on cardiac damage from sepsis in BALB/c mice.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Fenofibrate; Interleukin-6; Male; Mice; Mice, Inbred BALB C; PPAR alpha; Reactive Oxygen Species; Sepsis; Tumor Necrosis Factor-alpha | 2022 |